Weili Zhao
-
- Lymphoma Diagnosis and Treatment 63
- Oncology top 5%
- CAR-T cell therapy research 30
- Viral-associated cancers and disorders 24
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 20
- Cancer Research top 10%
- Immunology top 10%
- Immune Cell Function and Interaction 19
-
- Acute Myeloid Leukemia Research 10
-
- CNS Lymphoma Diagnosis and Treatment 7
-
- Cancer-related gene regulation 7
- Co-authors
- Pengpeng XuShu ChengLi WangAnne JaninQing ShiDi FuJinyan HuangSai‐Juan Chen
- Journals
- Advanced Materials (1 paper)Nature Communications (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- ChinaFranceUnited States
In The Last Decade
Weili Zhao
95 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 96
- Pathology and Forensic Medicine 568
- Oncology 582
- Genetics 193
- Cancer Research 221
- Immunology 282
Countries citing papers authored by Weili Zhao
This map shows the geographic impact of Weili Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weili Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weili Zhao more than expected).
Fields of papers citing papers by Weili Zhao
This network shows the impact of papers produced by Weili Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weili Zhao. The network helps show where Weili Zhao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weili Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 2 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 2 | |
| 7 | 2025 | 0 | |
| 8 | 2025 | 3 | |
| 9 | 2024 | 7 | |
| 10 | 2024 | 0 | |
| 11 | 2024 | 2 | |
| 12 | 2024 | 18 | |
| 13 | 2023 | 4 | |
| 14 | 2023 | 18 | |
| 15 | 2023 | 1 | |
| 16 | 2021 | 17 | |
| 17 | 2019 | 7 | |
| 18 | 2013 | 5 | |
| 19 | 2012 | 4 | |
| 20 | 2010 | 11 |
About Weili Zhao
Weili Zhao is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics, having authored 112 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (63 papers), CAR-T cell therapy research (30 papers), Viral-associated cancers and disorders (24 papers), Chronic Lymphocytic Leukemia Research (20 papers), Immune Cell Function and Interaction (19 papers), Acute Myeloid Leukemia Research (10 papers), CNS Lymphoma Diagnosis and Treatment (7 papers) and Cancer-related gene regulation (7 papers). The work is most often cited by research in Pathology and Forensic Medicine (568 citations), Oncology (582 citations) and Genetics (193 citations). Weili Zhao has collaborated with scholars based in China, France and United States. Frequent co-authors include Pengpeng Xu, Shu Cheng, Li Wang, Anne Janin, Li Wang, Qing Shi, Di Fu, Jinyan Huang, Sai‐Juan Chen and Xiao‐Jian Sun. Their work appears in journals such as Advanced Materials, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.